(NTLA) Intellia Therapeutics Monthly charts technical analysis
(NTLA) Intellia Therapeutics Monthly charts technical analysis Monthly analysis of Intellia Therapeutics | Buy/Sell Intellia Therapeutics
Intellia Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Intellia Therapeutics is 7342183
| Date | Closing Price | Open | High | Low | Volume |
| 03 Fri Oct 2025 | 20.22 | 17.38 | 21.75 | 17.31 | 17.62 Mn |
| 30 Tue Sep 2025 | 17.27 | 11.17 | 18.58 | 10.89 | 134.776 Mn |
| 29 Fri Aug 2025 | 11.35 | 11.30 | 12.10 | 9.82 | 90.769 Mn |
| 31 Thu Jul 2025 | 11.64 | 9.23 | 14.61 | 8.98 | 106.828 Mn |
| 30 Mon Jun 2025 | 9.38 | 6.93 | 10.52 | 6.92 | 95.049 Mn |
| 30 Fri May 2025 | 6.87 | 8.90 | 9.78 | 6.83 | 101.549 Mn |
| 30 Wed Apr 2025 | 8.87 | 7.08 | 8.94 | 5.90 | 68.874 Mn |
| 31 Mon Mar 2025 | 7.11 | 10.18 | 10.68 | 6.98 | 59.571 Mn |
| 28 Fri Feb 2025 | 10.09 | 9.79 | 12.84 | 8.96 | 65.686 Mn |
| 31 Fri Jan 2025 | 10.32 | 11.88 | 13.34 | 9.25 | 68.119 Mn |
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.06 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Monthly charts
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.06 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.